Shining a spotlight on pulmonary hypertension associated with interstitial lung disease care: The latest advances in diagnosis and treatment [0.03%]
关注间质性肺疾病相关肺动脉高压诊治进展
Steven D Nathan,Michael R Stinchon Jr,Sara Atcheson et al.
Steven D Nathan et al.
Pulmonary hypertension associated with interstitial lung disease (PH-ILD) is a complex condition in which 2 consequential diseases interact and increase negative outcomes. Although the pathophysiologic mechanisms of PH-ILD are not yet well ...
Implementation of an adherence pharmacy referral protocol for patients taking sacubitril/valsartan [0.03%]
依从性药房转诊协议在沙库巴曲缬沙坦用药患者中的实施效果
Brigid Perry,Justin Jakab,Brittiny Robinson et al.
Brigid Perry et al.
Background: Heart failure is a prevalent disease state associated with limitations in function, hospitalization, and death. The 2022 American Heart Association/American College of Cardiology/Heart Failure Society of Ameri...
Budget impact of aripiprazole once every 2 months long-acting injectable for adult patients with bipolar I disorder in the United States [0.03%]
美国成人I型双相障碍患者使用阿立哌唑长效注射剂（每月给药一次）的预算影响
Vakaramoko Diaby,Shubhram Pandey,Vassiki Sanogo et al.
Vakaramoko Diaby et al.
Background: Bipolar disorder is a severe recurrent, episodic psychiatric condition with a worldwide prevalence of approximately 1%, affecting more than 5 million adults in the United States in 2020. A subtype, bipolar I d...
Annual prevalence of geographic atrophy and wet age-related macular degeneration among Medicare Advantage enrollees in a US health plan [0.03%]
美国医保优势计划中年龄相关性黄斑变性的年度患病率
Vishal Saundankar,Mark Borns,Kelly Broderick et al.
Vishal Saundankar et al.
Background: Geographic atrophy (GA) is an advanced form of dry age-related macular degeneration (AMD) that can lead to visual impairment. Published studies estimate approximately 1 million people in the United States have...
Pharmacist-supported electronic outreach to address medication nonadherence for Medicare Advantage enrollees [0.03%]
药师支持的电子随访干预 Medicare 优势计划受试者用药非依从性的效果
Natasha Virrueta,Valerie Valdiviez,Trevor Beutel et al.
Natasha Virrueta et al.
Background: Improved medication adherence, represented as an increase in the proportion of days covered (PDC), to chronic medications is associated with better patient outcomes, yet effective strategies to improve adheren...
Cost-effectiveness models of non-small cell lung cancer: A systematic literature review [0.03%]
非小细胞肺癌的成本效益模型：系统文献回顾
Michael Willis,Andreas Nilsson,Zin Min Thet Lwin et al.
Michael Willis et al.
Background: Non-small cell lung cancer (NSCLC) presents a formidable global health challenge owing to significant morbidity, high mortality rates, and substantial economic burden. Recent advances in targeted therapies and...
Estimating optimal thresholds for adherence to RASA medications among older adults with hypertension [0.03%]
估算高血压老年人群RASA药物依从性阈值的最佳方法
Megha A Parikh,Sujith Ramachandran,Irene Nsiah et al.
Megha A Parikh et al.
Background: The Centers for Medicare and Medicaid Services (CMS) Star Ratings program incentivizes health plans in Medicare to improve performance on a variety of quality measures such as adherence to renin-angiotensin sy...
Dynamic changes in medication burden leading to fall and hospital readmissions in older adults: Toward a strategy for improving risk and managing costs [0.03%]
老年人用药负担的动态变化导致跌倒和再入院：降低风险和管理成本的战略方向
Rafia S Rasu,Christy Xavier,Nahid Rianon
Rafia S Rasu
The majority of a health plan's performance and designated Star Rating is related to medication-related behavior, eg, medication adherence, medication review, and reconciliation, that are intricately related to adverse drug events (ADEs). A...
Health care resource utilization and costs of Medicare-enrolled patients with HR+/HER2- metastatic breast cancer treated with a CDK4/6i in the first-line setting [0.03%]
医疗保险参保的人类表皮生长因子受体2阴性的激素受体阳性转移性乳腺癌患者在一线治疗中使用CDK4/6抑制剂的医疗资源利用和成本状况
Emma Behan,David L Veenstra,Aasthaa Bansal
Emma Behan
Background: The introduction of cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6is) has transformed the treatment landscape for patients with hormone receptor positive (HR+) and human epidermal growth factor receptor 2...